Injecting A Missing Gene Could Restore His Sight

The video discusses the impact of gene therapy on childhood blindness, focusing on Maverick, a child diagnosed with Leber's congenital amaurosis. It highlights the FDA-approved treatment Luxturna, which delivers a healthy copy of the RPE 65 gene to patients. The video details Maverick's journey from diagnosis to treatment and the significant improvements in his vision and independence post-treatment.

How does gene therapy aim to help patients with retinal degeneration?

What is the specific genetic condition that Maverick has?

What are some of the limitations of Maverick's vision due to his condition?

What was the significance of the FDA approval of gene therapy for Maverick's condition?

Describe the process of how the gene therapy is administered to patients.

What emotional challenges did Maverick's family face regarding his treatment?

What potential improvements in Maverick's life are anticipated after the treatment?